WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999011822) METHOD FOR PREDICTING PROGNOSIS AND TREATMENT RESPONSE FOR GENETICALLY BASED ABNORMALITIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/011822    International Application No.:    PCT/US1998/018261
Publication Date: 11.03.1999 International Filing Date: 03.09.1998
Chapter 2 Demand Filed:    18.03.1999    
IPC:
C12Q 1/68 (2006.01)
Applicants: GENE LOGIC INC. [US/US]; 708 Quince Orchard Road Gaithersburg, MD 20878 (US) (For All Designated States Except US).
EVANS, Steven [US/US]; (US) (For US Only)
Inventors: EVANS, Steven; (US)
Agent: JONDLE, Robert, J.; Rothwell, Figg, Ernst & Kurz Suite 701 East 555 13th Street N.W. Columbia Square Washington, DC 20004 (US)
Priority Data:
60/057,479 03.09.1997 US
Title (EN) METHOD FOR PREDICTING PROGNOSIS AND TREATMENT RESPONSE FOR GENETICALLY BASED ABNORMALITIES
(FR) PROCEDE DE PREDICTION DE PRONOSTIC ET DE REPONSE A UN TRAITEMENT, DESTINE A DES ANOMALIES GENETIQUES
Abstract: front page image
(EN)The present invention relates to a method for predicting prognosis and treatment response for genetically based abnormalities. The method utilizes clinically observable, collectible data from selected patient populations with diseases arising from genetic abnormalities, and uses such information to differentiate classes of patients with regard to specific differences in their genetic makeup, which in turn then characterizes outcomes such as prognosis and treatment response.
(FR)La présente invention se rapporte à un procédé de prédiction de pronostic et de réponse à un traitement, destiné à des anomalies génétiques. Dans ce procédé, on utilise des données pouvant être observées et collectées cliniquement, à partir de populations de patients présentant des maladies provoquées par des anomalies génétiques, et on utilise ces informations pour différentier des classes de patients en fonction de différences spécifiques constatées dans leur patrimoine génétique, ce qui permet alors de caractériser les évolutions, comme le pronostic et la réponse à un traitement.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)